Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Nicardipine mechanism of action?

See the DrugPatentWatch profile for Nicardipine

Nicardipine is a dihydropyridine calcium channel blocker. Its mechanism is:

- It blocks L-type ( Cav1.2 ) voltage-gated calcium channels in vascular smooth muscle cells.
- This reduces Ca2+ influx during depolarization, lowering intracellular calcium.
- Lower Ca2+ decreases activation of the calmodulin–MLC kinase pathway, causing relaxation of smooth muscle.
- Result: arteriolar (mostly arterial) vasodilation → reduced systemic vascular resistance and afterload, lower blood pressure.
- Effects on veins are minimal; reflex tachycardia can occur due to the BP drop.
- Nicardipine also increases coronary vasodilation, improving coronary blood flow.
- It has relatively greater vascular selectivity compared with non-DHP calcium channel blockers.



Other Questions About Nicardipine :

nicardipine generic name Nicardipine gtt? Nicardipine drip? Are there any alternative patents for nicardipine formulation? Are there any pending patents for nicardipine's ready to use version? Nicardipine infusion? Are any patents currently pending for nicardipine's new formulations?